hil-214
·Code: TAK-214
hil-214: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| HilleVax, Inc. (HLVX) | Phase 2 |
Clinical Trials (1)
Phase 2, Single-arm, Open-label Trial for Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of the Intramuscular HIL-214 Norovirus Vaccine in Adults Aged 18 to 49 Years
Frequently asked questions
Who is developing hil-214?
hil-214 is being developed by HilleVax, Inc..
How many clinical trials involve hil-214?
BioSniper tracks 1 clinical trial involving hil-214.
Get deeper analysis on hil-214
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis